These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 20308164)

  • 1. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.
    Refsland EW; Stenglein MD; Shindo K; Albin JS; Brown WL; Harris RS
    Nucleic Acids Res; 2010 Jul; 38(13):4274-84. PubMed ID: 20308164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.
    Hultquist JF; Lengyel JA; Refsland EW; LaRue RS; Lackey L; Brown WL; Harris RS
    J Virol; 2011 Nov; 85(21):11220-34. PubMed ID: 21835787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.
    Li J; Chen Y; Li M; Carpenter MA; McDougle RM; Luengas EM; Macdonald PJ; Harris RS; Mueller JD
    J Mol Biol; 2014 Mar; 426(6):1296-307. PubMed ID: 24361275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.
    Gillick K; Pollpeter D; Phalora P; Kim EY; Wolinsky SM; Malim MH
    J Virol; 2013 Feb; 87(3):1508-17. PubMed ID: 23152537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel HIV-1 restriction factor that is biologically distinct from APOBEC3 cytidine deaminases in a human T cell line CEM.NKR.
    Zhou T; Han Y; Dang Y; Wang X; Zheng YH
    Retrovirology; 2009 Apr; 6():31. PubMed ID: 19344514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
    Bonvin M; Greeve J
    Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.
    Lackey L; Law EK; Brown WL; Harris RS
    Cell Cycle; 2013 Mar; 12(5):762-72. PubMed ID: 23388464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function.
    Jang GM; Annan Sudarsan AK; Shayeganmehr A; Prando Munhoz E; Lao R; Gaba A; Granadillo Rodríguez M; Love RP; Polacco BJ; Zhou Y; Krogan NJ; Kaake RM; Chelico L
    Mol Cell Proteomics; 2024 May; 23(5):100755. PubMed ID: 38548018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
    Adolph MB; Ara A; Chelico L
    J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.
    Phalora PK; Sherer NM; Wolinsky SM; Swanson CM; Malim MH
    J Virol; 2012 Nov; 86(21):11712-24. PubMed ID: 22915799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.
    Albin JS; Harris RS
    Expert Rev Mol Med; 2010 Jan; 12():e4. PubMed ID: 20096141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
    Koning FA; Newman EN; Kim EY; Kunstman KJ; Wolinsky SM; Malim MH
    J Virol; 2009 Sep; 83(18):9474-85. PubMed ID: 19587057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.
    Sato K; Takeuchi JS; Misawa N; Izumi T; Kobayashi T; Kimura Y; Iwami S; Takaori-Kondo A; Hu WS; Aihara K; Ito M; An DS; Pathak VK; Koyanagi Y
    PLoS Pathog; 2014 Oct; 10(10):e1004453. PubMed ID: 25330146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary culture of human blood-retinal barrier cells and preliminary study of APOBEC3 expression: an in vitro study.
    Lin H; Zhang Z; Zhang H; Yan P; Wang Q; Bai L
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4436-43. PubMed ID: 19369234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
    Wichroski MJ; Robb GB; Rana TM
    PLoS Pathog; 2006 May; 2(5):e41. PubMed ID: 16699599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations.
    Duggal NK; Fu W; Akey JM; Emerman M
    Virology; 2013 Sep; 443(2):329-37. PubMed ID: 23755966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
    Langlois MA; Beale RC; Conticello SG; Neuberger MS
    Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.
    Doehle BP; Schäfer A; Wiegand HL; Bogerd HP; Cullen BR
    J Virol; 2005 Jul; 79(13):8201-7. PubMed ID: 15956565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.